Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors

Cancer Res. 2010 Jun 1;70(11):4550-9. doi: 10.1158/0008-5472.CAN-10-0339. Epub 2010 May 18.

Abstract

To capitalize on the response of tumor cells to XRT, we developed a controlled-release nanoparticle drug delivery system using a targeting peptide that recognizes a radiation-induced cell surface receptor. Phage display biopanning identified Gly-Ile-Arg-Leu-Arg-Gly (GIRLRG) as a peptide that selectively recognizes tumors responding to XRT. Membrane protein extracts of irradiated glioma cells identified glucose-regulated protein GRP78 as the receptor target for GIRLRG. Antibodies to GRP78 blocked the binding of GIRLRG in vitro and in vivo. Conjugation of GIRLRG to a sustained-release nanoparticle drug delivery system yielded increased paclitaxel concentration and apoptosis in irradiated breast carcinomas for up to 3 weeks. Compared with controls, a single administration of the GIRLRG-targeted nanoparticle drug delivery system to irradiated tumors delayed the in vivo tumor tripling time by 55 days (P = 0.0001) in MDA-MB-231 and 12 days in GL261 (P < 0.005). This targeting agent combines a novel recombinant peptide with a paclitaxel-encapsulating nanoparticle that specifically targets irradiated tumors, increasing apoptosis and tumor growth delay in a manner superior to known chemotherapy approaches.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Antineoplastic Agents, Phytogenic / chemistry
  • Apoptosis / drug effects
  • Bacteriophages / genetics
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / radiotherapy
  • Cell Growth Processes / drug effects
  • Cell Line, Tumor
  • Coculture Techniques
  • Delayed-Action Preparations
  • Drug Delivery Systems
  • Endoplasmic Reticulum Chaperone BiP
  • Endothelial Cells / cytology
  • Glioma / drug therapy*
  • Glioma / pathology
  • Glioma / radiotherapy
  • Heat-Shock Proteins / biosynthesis
  • Humans
  • Mice
  • Mice, Inbred C57BL
  • Mice, Nude
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Oligopeptides / genetics
  • Oligopeptides / metabolism
  • Oligopeptides / pharmacology
  • Paclitaxel / administration & dosage*
  • Paclitaxel / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Delayed-Action Preparations
  • Endoplasmic Reticulum Chaperone BiP
  • HSPA5 protein, human
  • Heat-Shock Proteins
  • Hspa5 protein, mouse
  • Oligopeptides
  • Recombinant Proteins
  • Paclitaxel